Literature DB >> 11311134

Cloning, expression and localization of human BM88 shows that it maps to chromosome 11p15.5, a region implicated in Beckwith-Wiedemann syndrome and tumorigenesis.

M Gaitanou1, P Buanne, C Pappa, N Georgopoulou, A Mamalaki, F Tirone, R Matsas.   

Abstract

Porcine BM88 is a neuron-specific protein that enhances neuroblastoma cell differentiation in vitro and may be involved in neuronal differentiation in vivo. Here we report the identification, by Western blotting, of homologous proteins in human and mouse brain and the isolation of their respective cDNAs. Several human and mouse clones were identified in the EST database using porcine BM88 cDNA as a query. A human and a mouse EST clone were chosen for sequencing and were found both to predict a protein of 149 amino acids, with 79.9% reciprocal identity, and 76.4% and 70.7% identities to the porcine protein, respectively. This indicated that the clones corresponded to the human and mouse BM88 homologues. In vitro expression in a cell-free system as well as transient expression in COS7 cells yielded polypeptide products that were recognized by anti-BM88 antibodies and were identical in size to the native BM88 protein. Northern-blot analysis showed a wide distribution of the gene in human brain whereas immunohistochemistry on human brain sections demonstrated that the expression of BM88 is confined to neurons. The initial mapping assignment of human BM88 to chromosome 11p15.5, a region implicated in Beckwith-Wiedemann syndrome and tumorigenesis, was retrieved from the UniGene database maintained at the National Centre for Biotechnology Information (NCBI, Bethesda, MD, U.S.A.). We confirmed this localization by performing fluorescence in situ hybridization on BM88-positive cosmid clones isolated from a human genomic library. These results suggest that BM88 may be a candidate gene for genetic disorders associated with alterations at 11p15.5.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11311134      PMCID: PMC1221787          DOI: 10.1042/bj3550715

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  61 in total

Review 1.  CDK inhibitors: positive and negative regulators of G1-phase progression.

Authors:  C J Sherr; J M Roberts
Journal:  Genes Dev       Date:  1999-06-15       Impact factor: 11.361

Review 2.  Apoptosis and cell division.

Authors:  L O'Connor; D C Huang; L A O'Reilly; A Strasser
Journal:  Curr Opin Cell Biol       Date:  2000-04       Impact factor: 8.382

3.  A 1.4-Mb high-resolution physical map and contig of chromosome segment 11p15.5 and genes in the LOH11A metastasis suppressor region.

Authors:  G Bepler; K C O'briant; Y C Kim; G Schreiber; D M Pitterle
Journal:  Genomics       Date:  1999-01-15       Impact factor: 5.736

4.  The N terminus of the murine p53 tumour suppressor is an independent regulatory domain affecting activation and thermostability.

Authors:  S Hansen; D P Lane; C A Midgley
Journal:  J Mol Biol       Date:  1998-01-30       Impact factor: 5.469

5.  Genomic imprinting of a human apoptosis gene homologue, TSSC3.

Authors:  M P Lee; A P Feinberg
Journal:  Cancer Res       Date:  1998-03-01       Impact factor: 12.701

6.  Co-localization of the glial cell-line derived neurotrophic factor and its functional receptor c-RET in a subpopulation of rat dorsal root ganglion neurons.

Authors:  T Honda; M Takahashi; Y Sugiura
Journal:  Neurosci Lett       Date:  1999-11-05       Impact factor: 3.046

7.  Early expression of the BM88 antigen during neuronal differentiation of P19 embryonal carcinoma cells.

Authors:  E Boutou; C Hurel; R Matsas
Journal:  Int J Dev Neurosci       Date:  2000 Apr-Jun       Impact factor: 2.457

8.  Strain-dependent developmental relaxation of imprinting of an endogenous mouse gene, Kvlqt1.

Authors:  S Jiang; M A Hemann; M P Lee; A P Feinberg
Journal:  Genomics       Date:  1998-11-01       Impact factor: 5.736

9.  Loss of DCC expression in neuroblastoma is associated with disease dissemination.

Authors:  M A Reale; M Reyes-Mugica; W E Pierceall; M C Rubinstein; L Hedrick; S L Cohn; A Nakagawara; G M Brodeur; E R Fearon
Journal:  Clin Cancer Res       Date:  1996-07       Impact factor: 12.531

10.  Gain of imprinting at chromosome 11p15: A pathogenetic mechanism identified in human hepatocarcinomas.

Authors:  C Schwienbacher; L Gramantieri; R Scelfo; A Veronese; G A Calin; L Bolondi; C M Croce; G Barbanti-Brodano; M Negrini
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

View more
  5 in total

1.  Expression of Mammalian BM88/CEND1 in Drosophila Affects Nervous System Development by Interfering with Precursor Cell Formation.

Authors:  Athanasios Tzortzopoulos; Dimitra Thomaidou; Maria Gaitanou; Rebecca Matsas; Efthimios Skoulakis
Journal:  Neurosci Bull       Date:  2019-05-11       Impact factor: 5.203

2.  BM88/CEND1 coordinates cell cycle exit and differentiation of neuronal precursors.

Authors:  Panagiotis K Politis; Georgia Makri; Dimitra Thomaidou; Markus Geissen; Hermann Rohrer; Rebecca Matsas
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-30       Impact factor: 11.205

3.  The 4C5 cell-impermeable anti-HSP90 antibody with anti-cancer activity, is composed of a single light chain dimer.

Authors:  Katerina Sidera; Avraam El Hamidieh; Avgi Mamalaki; Evangelia Patsavoudi
Journal:  PLoS One       Date:  2011-09-01       Impact factor: 3.240

4.  Functional Interactions between BM88/Cend1, Ran-binding protein M and Dyrk1B kinase affect cyclin D1 levels and cell cycle progression/exit in mouse neuroblastoma cells.

Authors:  Konstantinos Tsioras; Florentia Papastefanaki; Panagiotis K Politis; Rebecca Matsas; Maria Gaitanou
Journal:  PLoS One       Date:  2013-11-28       Impact factor: 3.240

Review 5.  Cend1, a Story with Many Tales: From Regulation of Cell Cycle Progression/Exit of Neural Stem Cells to Brain Structure and Function.

Authors:  Maria Gaitanou; Katerina Segklia; Rebecca Matsas
Journal:  Stem Cells Int       Date:  2019-05-02       Impact factor: 5.443

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.